science
A protein-degradation mechanism opens a new treatment route for an inherited arrhythmia
An international team has identified a protein-degradation mechanism that contributes to the development of an inherited form of catecholaminergic polymorphic ventricular tachycardia (CPVT), a disease that mainly affects children and young people. The study was led by researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), in collaboration with the University of Pavia and IRCCS Istituti Clinici Scientifici Maugeri in Italy.
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories
Mouse study reveals magnetic nanoparticles' potential for ectopic pregnancy diagnosis and treatment
Phys.org
Wood beneath German lake may reveal buildings 3,000 years older than region's first farms
Phys.org
Seventeen K-Pop Robots Take Over Rockefeller Center, One Demands to Be Called a Soul
Hoodline
Four Sets of Abstract Moral Systems
Overcoming Bias Economics Blog
A home for ‘Inspiration': See the space shuttle mockup's future Downey building
Nbc Los Angeles